Difficulty: Medium
Average Score: 77%
Practice
Anaphylaxis is a medical emergency. The MAINSTAY of therapy is early administration of
Correct answer
D
Rationale
In the management of anaphylaxis, the mainstay of therapy is the early administration of intramuscular epinephrine. Epinephrine acts quickly to reverse the severe manifestations of anaphylaxis, such as bronchoconstriction, vasodilation, and increased capillary permeability, by stimulating alpha and beta-adrenergic receptors. This helps to improve blood pressure, relieve airway constriction, and reduce hives and swelling.
Corticosteroids (Option A) are not considered first-line treatment for anaphylaxis. While they may be used to prevent a biphasic reaction or for their anti-inflammatory effects, they act too slowly to be the mainstay of therapy in an acute anaphylactic episode.
Antihistamines (Option B) and H2-receptor antagonists (Option C) can help relieve itching and hives associated with mild allergic reactions, but they are not sufficient to manage the potentially life-threatening symptoms of anaphylaxis. They do not address the cardiovascular and respiratory effects that can rapidly progress in anaphylaxis.
In an educational context, it is crucial for healthcare providers, especially those working with pediatric patients, to understand the importance of prompt recognition and treatment of anaphylaxis. Knowing that intramuscular epinephrine is the first-line therapy can help save lives in emergency situations. Training on how to administer epinephrine via auto-injectors should be a priority in pediatric nursing education to ensure timely and effective management of anaphylactic reactions in children.
Corticosteroids (Option A) are not considered first-line treatment for anaphylaxis. While they may be used to prevent a biphasic reaction or for their anti-inflammatory effects, they act too slowly to be the mainstay of therapy in an acute anaphylactic episode.
Antihistamines (Option B) and H2-receptor antagonists (Option C) can help relieve itching and hives associated with mild allergic reactions, but they are not sufficient to manage the potentially life-threatening symptoms of anaphylaxis. They do not address the cardiovascular and respiratory effects that can rapidly progress in anaphylaxis.
In an educational context, it is crucial for healthcare providers, especially those working with pediatric patients, to understand the importance of prompt recognition and treatment of anaphylaxis. Knowing that intramuscular epinephrine is the first-line therapy can help save lives in emergency situations. Training on how to administer epinephrine via auto-injectors should be a priority in pediatric nursing education to ensure timely and effective management of anaphylactic reactions in children.